ASH 2022 Conference Coverage
Playback speed
10 seconds
Results From the Phase 3 ALPINE Study: Zanubrutinib vs. Ibrutinib in R/R CLL & SLL
By
ASH 2022 Conference Coverage
FEATURING
Jennifer Brown
By
ASH 2022 Conference Coverage
FEATURING
Jennifer Brown
193 views
April 14, 2023
Login to view comments.
Click here to Login
Leukemia